Dr. Allan V Kalueff



Academic Degree(s)






Current Position

  • Professor, School of Pharmaceutical Sciences, Southwest University, Chongqing, China


Professional Experience

  • 2014-2017 Distinguished Chair Professor of Neuroscience and Pharmacology, Guangdong Ocean University, China
  • 2009-2012 Assistant Professor of Pharmacology, Tulane University Medical School, New Orleans, LA, USA
  • 2008-2009 Assistant Professor of Physiology, Georgetown University Medical School, Washington DC, USA
  • 2005-2008 Post-doctoral Research Fellow, National Institute of Mental Health, Bethesda, USA
  • 2003-2005 Researcher, Medical School, Tampere University, Tampere, Finland
  • 1996-2003 Director of Research, Centre for Physiology and Biochemical Research, Kiev, Ukraine
  • 1996 Visiting Academic Scientist, University of Birmingham Medical School, Birmingham, UK
  • 1995 Academic Researcher, Bristol University Medical School, Bristol, UK


Education & Training

  • 1989-1996 BS/MS in Physiology (Summa Cum Laude), Moscow State University, Russia
  • 2003 PhD in Physiology, RUDN State University, Moscow, Russia
  • 2003-2005 Postdoctoral Fellow in Anatomy, Neuroscience, Tampere University Medical School, Tampere, Finland
  • 2005 PhD in Anatomy, Tampere University, Tampere, Finland
  • 2005-2008 Postdoctoral Research Fellow in Neuroscience and Pharmacology, NIMH/NIH, Bethesda, USA



  • 2007-2010 NARSAD Young Investigator Award
  • 2009-2010 Tulane-LSU Pilot CRECP Grant
  • 2010 LA Board of Regents P-Fund grant
  • 2011-2012 NIH/NIDA R03 SOAR Grant and supplement
  • 2011 Tulane Pilot Grant
  • 2012 LA BoR Opt-In II Grant


Selected Publication

  • Kyzar EJ, Nichols CN, Nichols D, Gainetdinov RR, Kalueff AV. Psychedelic drugs in biomedicine. Trends in Pharmacological Sciences (TIPS), 2017, in press. [IF = 10.0]
  • Kalueff AV, Stewart AM, Graybiel AM, Berridge KC, Fentress JC. Neurobiology of rodent self-grooming and its value for translational neuroscience research. Nature Reviews Neuroscience, 2016, 17, 45-59 [IF = 31.2]
  • Song C, Berridge KC, Kalueff AV. 'Stressing' rodent self-grooming for neuroscience research. Nature Reviews Neuroscience, 2016, 591-592 [IF = 31.2]
  • Song C, Shieh SH, Wu YS, Kalueff AV, Gaikwad S, Su KP. The role of omega-3 polyunsaturated fatty acids eicosapentaenoic and docosahexaenoic acids in the treatment of major depression and Alzheimer’s disease: acting separately or synergistically? Prog Lipid Res, 2016, in press [IF = 10.02]
  • Stewart AM, Kalueff AV. Controlled substances and innovation of biomedicine: a preclinical perspective. Nature Reviews Neurosciences, 2013, 15, 34-35 [IF = 31.2]
  • Kalueff AV, Stewart AM, Gottesman I. Targeting dynamic interplay among disordered domains or endophenotypes to understand complex neuropsychiatric disorders: Translational lessons from preclinical models, Neuroscience and Biobehavioral Reviews, 2015, 53:25-36 [IF = 10.1]
  • Stewart AM, Ullmann J, Norton WJ, Parker MO, Brennan CH, Gerlai R, Kalueff AV. Molecular psychiatry of zebrafish. Molecular Psychiatry, 2015, 20, 2-17 [IF = 15.40]
  • Kalueff AV., Stewart AM, I Gottesman. Rethinking CNS disorders: time for new drug targets? Trends in Pharmacological Sciences (TIPS), 2014, 35, 491-492. [IF = 10.0]
  • Kalueff AV., Stewart AM, Gerlai R. Zebrafish as an emerging model for complex brain disorders. Trends in Pharmacological Sciences (TIPS), 2014. [IF = 10.0]
  • Stewart AM, Braubach O, Gerlai R, Kalueff AV. Zebrafish models for translational neuroscience research: from tank to bedside. Trends in Neurosciences TINS, 2014 [IF = 14.0]